AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 24633406
Drug: Gradual tapering
RxNorm normalized name: mitapivat
DrugBank: Mitapivat (DB16236)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Gradual tapering of clopidogrel maintenance therapy over four weeks
Trial: 24633406
Drug: Abrupt discontinuation
RxNorm normalized name: guaifenesin / hydrocodone bitartrate / phenylephrine hydrochloride Oral Solution [Entex HC Discontinued]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Abrupt discontinuation of clopidogrel therapy after continued therapy for an additional four weeks
Trial: 18808445
Drug: Morphine 0.05
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morphine 0.05 mg/kg
Trial: 8915035
Drug: Donepezil 5
RxNorm normalized name: donepezil 5 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Donepezil 5 mg/day
Trial: 10232717
Drug: Propofol (2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propofol (2.5 mg x kg(‐1))
Trial: 10232717
Drug: Etomidate (0.3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Etomidate (0.3 mg x kg(‐1))
Trial: 2257858
Drug: Nifedipine 5
RxNorm normalized name: nifedipine 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nifedipine 5 mg
Trial: 1938849
Drug: Nifedipine 15
RxNorm normalized name: nifedipine 15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nifedipine 15 mg
Trial: 2257858
Drug: Nicardipine 20
RxNorm normalized name: nicardipine 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nicardipine 20 mg
Trial: 2350528
Drug: Nicardipine 30
RxNorm normalized name: niCARdipine 30 mg oral capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nicardipine 30 mg
Trial: 6805361
Drug: 0 mg
RxNorm normalized name: RNA 180 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0 mg morphine in 1 ml saline + 6 ml bupivacaine 0.5%
Trial: 6805361
Drug: 4 mg
RxNorm normalized name: lutein 4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 mg morphine in 1 ml saline + 6 ml bupivacaine 0.5%
Trial: 6805361
Drug: 4 mg
RxNorm normalized name: lutein 4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 mg morphine in 6 ml saline
Trial: 28849623
Drug: Intravenous (IV)
RxNorm normalized name: intravenous (IV) infusion pump
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous (IV) iron sucrose
Trial: 30074935
Drug: Oral ferrous
RxNorm normalized name: ferrous fumarate Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral ferrous sulfate
Trial: 24717794
Drug: TAA‐AQ (triamcinolone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TAA‐AQ (triamcinolone acetonide aqueous nasal spray, 110 μg for 2-11 years old or 220 μg for 6-11 years old)
Trial: 24717794
Drug: TAA‐AQ (triamcinolone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TAA‐AQ (triamcinolone acetonide aqueous nasal spray)
Trial: 18996033
Drug: 1.7 mL
RxNorm normalized name: DENOSUMAB 120 MG/1.7 ML INJ
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.7 mL of 4% articaine/HCl injected into the buccal vestibule
Trial: 17617286
Drug: C.E.R.A. administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: C.E.R.A. administered at one of three doses (0.25 pg/150 IU, 0.4 pg/150 IU, or 0.6 pg/150 IU) with frequency subgroups of QW or Q2W.
Trial: 15359376
Drug: Clomethiazole (1st
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clomethiazole (1st day: 3 x 384 mg, 2nd day: 4 x 384 mg, 3rd day: 3 x 384 mg, 4th day: 2 x 384 mg, 5th day: 1 x 384 mg)
Trial: 28720132
Drug: IND/GLY 110/50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IND/GLY 110/50 μg q.d.
Trial: 15870668
Drug: Glutamine supplement
RxNorm normalized name: Glutamine
DrugBank: L-Glutamine (DB00130)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Glutamine supplement (0.6 g.kg ‐1 .d ‐1)
Trial: 15870668
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no glutamine supplement)
Trial: 7880409
Drug: Ketorolac gel
DrugBank: Ketorolac (DB00465)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ketorolac gel
Trial: 3066339
Drug: PGI2 infusion
RxNorm normalized name: PGI2
DrugBank: Epoprostenol (DB01240)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: PGI2 infusion (4 to 12 hours daily)
Trial: 31705683
Drug: Probiotic group
RxNorm normalized name: Rezyst Probiotic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Probiotic group receiving drops and lozenges containing L. reuteri (ATCC PTA 5289 & DSM 17938)
Trial: 25554404
Drug: Eplerenone 25
RxNorm normalized name: eplerenone 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Eplerenone 25 mg orally every other day for the first month and once daily thereafter, in addition to background therapy with ACEI or ARB.
Trial: 22961092
Drug: Cranberry juice
RxNorm normalized name: cranberry juice
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cranberry juice (UR65), 125 mL once daily for 24 weeks
Trial: 22961092
Drug: Placebo beverage,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo beverage, 125 mL once daily for 24 weeks
Trial: 16011136
Drug: Pterygopalatine fossa
RxNorm normalized name: Fossaoprin SPG2 KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pterygopalatine fossa infiltration with 2 mL of 2% lidocaine and 1:80,000 adrenalin
Trial: 10090355
Drug: 15 g
RxNorm normalized name: 15 g/31 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 g of alcohol
Trial: 10090355
Drug: 30 g
RxNorm normalized name: Lancet Unilet 30 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 g of alcohol
Trial: 28514235
Drug: Ondansetron (8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ondansetron (8 mg intravenous pretreatment)
Trial: 24237724
Drug: Aloe vera
RxNorm normalized name: ALOE VERA
DrugBank: Aloe vera leaf (DB13906)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aloe vera gel (n = 15 per category)
Trial: 19097758
Drug: Ertapenem 1
RxNorm normalized name: ertapenem 1000 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ertapenem 1 g intravenous dose
Trial: 9551674
Drug: GM-CSF alone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GM-CSF alone (65-250 microg/m2 three times weekly for 6 months)
Trial: 9551674
Drug: Interferon alone
RxNorm normalized name: Interferon Gamma
DrugBank: Interferon Gamma (DB15753)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interferon alone (3 mU three times weekly for 6 months)
Trial: 9551674
Drug: Interferon +
RxNorm normalized name: Interferon Gamma
DrugBank: Interferon Gamma (DB15753)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interferon + GM-CSF (3 mU + 250 microg/m2 three times weekly for 6 months)
Trial: 20652004
Drug: GM-CSF treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GM-CSF treatment
Trial: 7358200
Drug: Loxapine (10-150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Loxapine (10-150 mg/day)
Trial: 7358200
Drug: Thioridazine (150-750
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thioridazine (150-750 mg/day)
Trial: 20940383
Drug: Placebo implants
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo implants (4 implants)
Trial: 20940383
Drug: Buprenorphine implants
RxNorm normalized name: buprenorphine Drug Implant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Buprenorphine implants
Trial: 18426577
Drug: Relora (250
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Relora (250 mg capsules, 3 times daily for 6 weeks)
Trial: 14582585
Drug: Triclosan-containing dental
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triclosan-containing dental gel (0.3%) applied for 5 min twice daily for 14 days
Trial: 10757567
Drug: Oxycodone-thiopental
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxycodone-thiopental
Trial: 15366589
Drug: Huannao Yicong
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Huannao Yicong capsule (HYC) 3 capsules, 3 times daily for 2 months
Trial: 10024707
Drug: Active treatment
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active treatment (ear electroacupuncture with two needles at an active site and self-retained ear seeds for two weeks)
Trial: 10024707
Drug: Placebo treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo treatment (ear electroacupuncture with two needles at a placebo site and self-retained ear seeds for two weeks)
Trial: 7981930
Drug: Colestipol (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Colestipol (10 g)
Trial: 23199101
Drug: Total arch
RxNorm normalized name: Colgate Total Mouthwash
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Total arch distalization using orthodontic mini‐implants (OMIs) combined with interproximal stripping (IPS)
Trial: 16482236
Drug: Standard volume
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard volume PEG (4 L PEG)
Trial: 8149110
Drug: d-fenfluramine (45
FDA approved: no
EMA approved: no
PMDA approved: no
Description: d-fenfluramine (45 mg/day)
Trial: 26471280
Drug: Intervention group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intervention group with printed symptom summaries available before each weekly office visit
Trial: 16287954
Drug: High-dose atorvastatin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose atorvastatin (80 mg/d)
Trial: 17606955
Drug: Low-dose atorvastatin
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose atorvastatin (10 mg/d)
Trial: 10052024
Drug: Ondansetron (8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ondansetron (8 mg intravenous)
Trial: 7887644
Drug: Arm A:
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Arm A: 250 mg/m2 of l‐LV and 600 mg/m2 of 5‐FU weekly
Trial: 7887644
Drug: Arm B:
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Arm B: 100 mg/m2 of l‐LV and 370 mg/m2 of 5‐FU for 5 consecutive days
Trial: 7887644
Drug: Arm C:
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Arm C: 10 mg/m2 of l‐LV and 370 mg/m2 of 5‐FU for 5 consecutive days
Trial: 2403824
Drug: Native prothrombin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Native prothrombin antigen (therapeutic range, 12 to 24 micrograms/mL)
Trial: 240140
Drug: Alclofenac 500
RxNorm normalized name: Acéclofénac
DrugBank: Aceclofenac (DB06736)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Alclofenac 500 mg
Trial: 29202730
Drug: Biomarker-guided antibiotic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Biomarker-guided antibiotic treatment of stroke associated pneumonia
Trial: 23707824
Drug: Internet counseling
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Internet counseling (daily e-mails with recommended activities through Pfizer's GetQuit program)
Trial: 23480640
Drug: Once-daily darunavir/ritonavir
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Once-daily darunavir/ritonavir (DRV/r) 800/100 mg
Trial: 22189150
Drug: Lopinavir/ritonavir 800/200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lopinavir/ritonavir 800/200 mg
Trial: 6360815
Drug: Propranolol (non‐selective
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol (non‐selective beta 1 and beta 2 blocker)
Trial: 6360815
Drug: Prazosin (alpha
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prazosin (alpha blocker)
Trial: 6360815
Drug: Atenolol (selective
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atenolol (selective beta 1 blocker)
Trial: 27636923
Drug: Pulmonary rehabilitation
RxNorm normalized name: Lobaria pulmonaria extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pulmonary rehabilitation (PR) cycle in addition to standard therapy for COPD
Trial: 9663842
Drug: Ranitidine effervescent
RxNorm normalized name: ranitidine Effervescent Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ranitidine effervescent tablets 150 mg
Trial: 9663842
Drug: Ranitidine effervescent
RxNorm normalized name: ranitidine Effervescent Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ranitidine effervescent tablets 300 mg
Trial: 9663842
Drug: Famotidine fast-dissolving
RxNorm normalized name: melatonin
DrugBank: Melatonin (DB01065)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Famotidine fast-dissolving tablets 20 mg
Trial: 9663842
Drug: Omeprazole capsules
RxNorm normalized name: Omeprazole
DrugBank: Omeprazole (DB00338)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Omeprazole capsules 20 mg
Trial: 27189295
Drug: Dexmedetomidine (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexmedetomidine (0.5 μg/kg) for 5 minutes
Trial: 27189295
Drug: Remifentanil with
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Remifentanil with an effect site concentration of 1.5 ng/mL until endotracheal extubation
Trial: 25213871
Drug: Best physician's
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Best physician's choice (BPC) chemotherapy
Trial: 22700854
Drug: Dabigatran 110
RxNorm normalized name: dabigatran 110 mg oral capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dabigatran 110 mg (urgent surgery)
Trial: 22700854
Drug: Warfarin (urgent
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Warfarin (urgent surgery)
Trial: 17140102
Drug: Gene and
RxNorm normalized name: lipid nanoparticle encapsulating single guide RNA (G012267) targeting the human KLKB1 gene and messenger RNA (mRNA000042) encoding Cas9
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gene and cell therapy aimed at stimulating angiogenesis
Trial: 22464408
Drug: Oral contraceptives
RxNorm normalized name: VCF Contraceptive
DrugBank: Nonoxynol-9 (DB06804)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral contraceptives (OC)
Trial: 9351415
Drug: Non-users of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-users of oral contraceptives
Trial: 8931610
Drug: Radiation therapy
RxNorm normalized name: Sensitizers used in photodynamic/radiation therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Radiation therapy (n = 416)
Trial: 21102369
Drug: Subconjunctival lidocaine
RxNorm normalized name: Lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Subconjunctival lidocaine injection
Trial: 20570360
Drug: Subconjunctival lidocaine
RxNorm normalized name: Lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Subconjunctival lidocaine injection (crossover group)
Trial: 20570360
Drug: Sham injection
RxNorm normalized name: BLACK BEAN ANTI HAIR LOSS SHAM POO SET KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sham injection (crossover group)
Trial: 8915574
Drug: Increased levels
RxNorm normalized name: peanut allergenic extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Increased levels of trkA receptors in astrocytes in the CA1 region of Alzheimer's disease hippocampi, associated with beta-amyloid-positive plaques.
Trial: 8915574
Drug: High levels
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High levels of truncated trkB receptors found in senile plaques in Alzheimer's disease brains.
Trial: 8915574
Drug: Full-length trkB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Full-length trkB receptor expression in glial-like cells in the hippocampus of Alzheimer's disease brains.
Trial: 8915574
Drug: Elevated trk
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Elevated trk receptor mRNA levels in Alzheimer's disease brains as indicated by in-situ hybridisation studies.
Trial: 1910794
Drug: Alfentanil 0.01
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alfentanil 0.01 mg/kg
Trial: 27852903
Drug: Teriparatide (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Teriparatide (20 μg/day)
Trial: 27852903
Drug: Risedronate (35
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Risedronate (35 mg/week)
Trial: 21519752
Drug: 5·10(8) cfu/day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5·10(8) cfu/day of L. plantarum CECT7315/7316 (low probiotic dose) (n = 13)
Trial: 21519752
Drug: 5·10(9) cfu/day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5·10(9) cfu/day of the probiotic mixture (high probiotic dose) (n = 19)
Trial: 12767365
Drug: Alternating therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alternating therapy with mitomycin C (MMC) and bacillus Calmette‐Guerin (BCG)
Trial: 27603424
Drug: BCG monotherapy
RxNorm normalized name: Tice BCG
DrugBank: Bacillus calmette-guerin substrain tice live antigen (DB10343)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BCG monotherapy
Trial: 3910908
Drug: Native thrombolytic
RxNorm normalized name: Castanea sative leaf extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Native thrombolytic drugs (streptokinase or urokinase) administered to 30 patients
Trial: 28272175
Drug: Nebulized fluticasone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nebulized fluticasone 1,000 µg
Trial: 23690356
Drug: Tetracaine hydrochloride-oxymetazoline
RxNorm normalized name: oxymetazoline / tetracaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tetracaine hydrochloride-oxymetazoline hydrochloride nasal spray bilaterally with sham injection
Trial: 23690356
Drug: Intra-oral lidocaine-epinephrine
RxNorm normalized name: epinephrine / lidocaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intra-oral lidocaine-epinephrine injection with buffered saline nasal spray bilaterally
Trial: 20949350
Drug: Risperidone (6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Risperidone (6 mg/day) plus sildenafil (75 mg/day)
Trial: 14649206
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (Steroid, cyclophosphamide, losartan, and dipyridamole)
Trial: 3193409
Drug: Parenteral combination
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Parenteral combination therapy (cefoxitin plus doxycycline or ceftizoxime plus doxycycline)
Trial: 3193409
Drug: Monotherapy (ceftizoxime
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Monotherapy (ceftizoxime alone)
Trial: 25971261
Drug: Low-dose ribavirin
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose ribavirin
Trial: 15014183
Drug: BIBN 4096
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BIBN 4096 BS 2.5 mg
Trial: 15014183
Drug: BIBN 4096
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BIBN 4096 BS (all doses)
Trial: 9043563
Drug: Intervention 1:
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intervention 1: Placement of a brightly colored label in the medication drawer and on the cover of the nursing medication card flip-chart.
Trial: 8172701
Drug: Surgical treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Surgical treatment evaluation method
Trial: 31697729
Drug: Caffeine (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Caffeine (5 mg.kg-1 body mass)
Trial: 19906075
Drug: Alitretinoin 30
RxNorm normalized name: Alitretinoin
DrugBank: Alitretinoin (DB00523)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Alitretinoin 30 mg once daily for 12-24 weeks
Trial: 18678156
Drug: Medication group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medication group (no EA)
Trial: 12580681
Drug: Home intervention
RxNorm normalized name: benzalkonium
DrugBank: Benzalkonium (DB11105)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Home intervention with weekly visits from 0 to 6 months and biweekly visits from 6 to 18 months
Trial: 8768860
Drug: Combination recombinant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination recombinant human GH (rhGH; 0.34 mg, sc, twice daily) and rhIGF‐I (5.0 mg, sc, twice daily)
Trial: 29857783
Drug: Fluticasone propionate/formoterol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluticasone propionate/formoterol fumarate (Flutiform®; 100/10 µg b.i.d.)
Trial: 27163503
Drug: 25 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 25 mg Opicapone (OPC)
Trial: 27163503
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg Opicapone (OPC)
Trial: 20377423
Drug: RBV 2000
RxNorm normalized name: RBV
DrugBank: Ribavirin (DB00811)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: RBV 2000 mg/day plus EPO 30,000 IU/week
Trial: 20377423
Drug: Weight-based RBV
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Weight-based RBV (1000-1200 mg/day)
Trial: 2265733
Drug: Conventional injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional injection therapy (CT)
Trial: 30320641
Drug: Dexamethasone (8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexamethasone (8 mg) in group D
Trial: 30320641
Drug: Lidocaine (1.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lidocaine (1.5 mg/kg) in group L
Trial: 30320641
Drug: Lidocaine (1.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lidocaine (1.5 mg/kg) with Dexamethasone (8 mg) in group DL
Trial: 27159624
Drug: Group DM
RxNorm normalized name: Dextromethorphan
DrugBank: Dextromethorphan (DB00514)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Group DM (0.1 mg/kg dezocine + 0.05 mg/kg midazolam)
Trial: 27159624
Drug: Groups D
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Groups D and DM (0.1 mg/kg dezocine)
Trial: 27159624
Drug: Group D
RxNorm normalized name: Prostaglandin group D
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group D (0.1 mg/kg dezocine)
Trial: 27159624
Drug: Groups M
RxNorm normalized name: Coenzyme M
DrugBank: Coenzyme M (DB09110)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Groups M and DM (0.05 mg/kg midazolam)
Trial: 12600867
Drug: Iron-only supplementation,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iron-only supplementation, 6 days/week, containing 60 mg Fe
Trial: 10978257
Drug: Simvastatin therapy
RxNorm normalized name: Simvastatin
DrugBank: Simvastatin (DB00641)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Simvastatin therapy (20 mg per day for 4 months)
Trial: 8984133
Drug: Enalapril 20
RxNorm normalized name: enalapril 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enalapril 20 mg once a day